Roger Song
Stock Analyst at Jefferies
(3.27)
# 2,419
Out of 4,457 analysts
253
Total ratings
43.1%
Success rate
3.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Rated: Buy | $46 → $83 | $55.72 | +48.96% | 5 | Jun 21, 2026 | |
| MANE Veradermics | Maintained: Buy | $138 | $123.58 | +11.67% | 3 | Jun 16, 2026 | |
| NRIX Nurix Therapeutics | Maintained: Buy | $45 | $23.85 | +88.68% | 5 | Jun 15, 2026 | |
| KLRA Kailera Therapeutics | Maintained: Buy | $48 | $21.70 | +121.20% | 2 | May 28, 2026 | |
| AVLN Avalyn Pharma | Initiated Coverage: Buy | $52 | $31.13 | +67.04% | 1 | May 26, 2026 | |
| SABS SAB Biotherapeutics | Initiated Coverage: Buy | $11 | $3.90 | +182.05% | 1 | May 20, 2026 | |
| UTHR United Therapeutics | Maintained: Buy | $668 → $733 | $544.92 | +34.52% | 15 | May 19, 2026 | |
| FATE Fate Therapeutics | Initiated Coverage: Buy | $4 | $2.42 | +65.29% | 1 | May 19, 2026 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintained: Buy | $58 → $71 | $62.41 | +13.76% | 6 | Apr 28, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Buy | $10 | $2.22 | +350.45% | 1 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $8 → $2 | $11.20 | -82.14% | 15 | Apr 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 → $18 | $5.68 | +216.90% | 4 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $24.95 | +148.50% | 6 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $3.11 | +350.16% | 3 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $16 | $3.74 | +327.81% | 5 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $92.49 | -51.35% | 3 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $51.69 | +141.83% | 17 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $245 → $371 | $378.15 | -1.89% | 2 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $39.54 | +155.44% | 11 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $42 | $14.48 | +190.06% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $154 | $74.50 | +106.71% | 6 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $121 | $65.39 | +85.04% | 11 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $10.97 | +155.24% | 20 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $6.48 | +147.10% | 1 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $40 | $33.35 | +19.94% | 3 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.39 | +259.71% | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $17 | $0.5664 | +2,901.41% | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $4 | $3.08 | +29.87% | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $53.85 | -33.15% | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.8 → $1.8 | $1.12 | +60.71% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $2.94 | n/a | 16 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $0.572 | n/a | 4 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $5.02 | n/a | 13 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 | $121.63 | n/a | 6 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $1.11 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $146 | $57.72 | n/a | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $18 | $1.78 | n/a | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $3.45 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.0075 | n/a | 4 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 | $25.55 | n/a | 2 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $97 → $137 | $123.51 | n/a | 4 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $25 | $9.36 | n/a | 16 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $1.5 | $4.41 | n/a | 6 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $3 | $18.00 | n/a | 5 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $68 | $37.44 | n/a | 2 | Nov 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $4.93 | n/a | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $154.84 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $1.91 | n/a | 1 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $10.49 | n/a | 1 | Apr 13, 2021 |
TG Therapeutics
Jun 21, 2026
Rated: Buy
Price Target: $46 → $83
Current: $55.72
Upside: +48.96%
Veradermics
Jun 16, 2026
Maintained: Buy
Price Target: $138
Current: $123.58
Upside: +11.67%
Nurix Therapeutics
Jun 15, 2026
Maintained: Buy
Price Target: $45
Current: $23.85
Upside: +88.68%
Kailera Therapeutics
May 28, 2026
Maintained: Buy
Price Target: $48
Current: $21.70
Upside: +121.20%
Avalyn Pharma
May 26, 2026
Initiated Coverage: Buy
Price Target: $52
Current: $31.13
Upside: +67.04%
SAB Biotherapeutics
May 20, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $3.90
Upside: +182.05%
United Therapeutics
May 19, 2026
Maintained: Buy
Price Target: $668 → $733
Current: $544.92
Upside: +34.52%
Fate Therapeutics
May 19, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $2.42
Upside: +65.29%
Kiniksa Pharmaceuticals International,
Apr 28, 2026
Maintained: Buy
Price Target: $58 → $71
Current: $62.41
Upside: +13.76%
Allogene Therapeutics
Apr 15, 2026
Maintained: Buy
Price Target: $10
Current: $2.22
Upside: +350.45%
Apr 12, 2026
Downgraded: Hold
Price Target: $8 → $2
Current: $11.20
Upside: -82.14%
Mar 26, 2026
Rated: Buy
Price Target: $26 → $18
Current: $5.68
Upside: +216.90%
Mar 26, 2026
Maintained: Buy
Price Target: $62
Current: $24.95
Upside: +148.50%
Mar 23, 2026
Maintained: Buy
Price Target: $14
Current: $3.11
Upside: +350.16%
Mar 18, 2026
Reiterated: Buy
Price Target: $8 → $16
Current: $3.74
Upside: +327.81%
Mar 11, 2026
Maintained: Buy
Price Target: $45
Current: $92.49
Upside: -51.35%
Feb 27, 2026
Maintained: Buy
Price Target: $125
Current: $51.69
Upside: +141.83%
Feb 17, 2026
Maintained: Buy
Price Target: $245 → $371
Current: $378.15
Upside: -1.89%
Feb 12, 2026
Maintained: Buy
Price Target: $101
Current: $39.54
Upside: +155.44%
Jan 22, 2026
Maintained: Buy
Price Target: $13 → $42
Current: $14.48
Upside: +190.06%
Dec 19, 2025
Maintained: Buy
Price Target: $154
Current: $74.50
Upside: +106.71%
Dec 17, 2025
Maintained: Buy
Price Target: $121
Current: $65.39
Upside: +85.04%
Dec 10, 2025
Maintained: Buy
Price Target: $28
Current: $10.97
Upside: +155.24%
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $16
Current: $6.48
Upside: +147.10%
Sep 9, 2025
Maintained: Buy
Price Target: $80 → $40
Current: $33.35
Upside: +19.94%
Aug 28, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.39
Upside: +259.71%
Aug 22, 2025
Maintained: Buy
Price Target: $9 → $17
Current: $0.5664
Upside: +2,901.41%
Aug 20, 2025
Maintained: Buy
Price Target: $12 → $4
Current: $3.08
Upside: +29.87%
Aug 15, 2025
Initiated Coverage: Buy
Price Target: $36
Current: $53.85
Upside: -33.15%
Aug 13, 2025
Maintained: Buy
Price Target: $4.8 → $1.8
Current: $1.12
Upside: +60.71%
Jun 26, 2025
Maintained: Buy
Price Target: $28
Current: $2.94
Upside: n/a
Jun 11, 2025
Maintained: Buy
Price Target: $10 → $8
Current: $0.572
Upside: n/a
Apr 24, 2025
Maintained: Buy
Price Target: $7
Current: $5.02
Upside: n/a
Apr 10, 2025
Maintained: Buy
Price Target: $68
Current: $121.63
Upside: n/a
Apr 1, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $1.11
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: $146
Current: $57.72
Upside: n/a
Mar 26, 2025
Rated: Buy
Price Target: $12 → $18
Current: $1.78
Upside: n/a
Mar 14, 2025
Initiated Coverage: Buy
Price Target: $7
Current: $3.45
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $8
Current: $0.0075
Upside: n/a
Jan 10, 2025
Rated: Buy
Price Target: $35
Current: $25.55
Upside: n/a
Dec 20, 2024
Maintained: Buy
Price Target: $97 → $137
Current: $123.51
Upside: n/a
Oct 16, 2024
Maintained: Buy
Price Target: $31 → $25
Current: $9.36
Upside: n/a
Aug 21, 2024
Downgraded: Hold
Price Target: $14 → $1.5
Current: $4.41
Upside: n/a
Mar 27, 2024
Maintained: Buy
Price Target: $5 → $3
Current: $18.00
Upside: n/a
Nov 5, 2023
Rated: Buy
Price Target: $68
Current: $37.44
Upside: n/a
Jul 29, 2022
Initiated Coverage: Buy
Price Target: $9
Current: $4.93
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $6
Current: $154.84
Upside: n/a
Apr 29, 2021
Maintained: Buy
Price Target: $23
Current: $1.91
Upside: n/a
Apr 13, 2021
Initiated Coverage: Buy
Price Target: $29
Current: $10.49
Upside: n/a